Jacobson Resonance Enterprises, Inc. (OTC-BB-JRSE) Executes Letter of Intent With Institutional Finance Group, Inc. and IFG Private Equity, LLC for Ten Million Dollars

Apr 11, 2001, 01:00 ET from Jacobson Resonance Enterprises, Inc.

    BOYNTON BEACH, Fla., and ATLANTA, April 11 /PRNewswire/ --
 Jacobson Resonance Enterprises, Inc. (OTC Bulletin Board:   JRSE) announced
 today the execution of a letter of intent subject to a more definitive
 agreement of an irrevocable three (3) year funding commitment with
 Institutional Finance Group, and IFG Private Equity LLC for ten million
 dollars ($10,000,000).
     While all the details have not been made public and are subject to final
 approval and due diligence by both Companies the irrevocable three-year
 commitment from IFG calls for providing JRSE with a maximum equity available
 line of ten million dollars ($10,000,000) based on ninety-five percent (95%)
 of the market price per share of JRSE stock averaged over the next twenty (20)
 days of trading of each pricing period. JRSE has the right and control to set
 up a floor price for the stock if and when it wishes to utilize said equity
 line during the three (3) year irrevocable commitment.
     IFG has already commenced its due diligence process which is expected to
 be concluded within the next few weeks and final approval and definitive
 lending agreement to be executed is anticipated within the next thirty (30)
 days.
     Dan Hollis, Chief Operating Officer of IFG said, "Our company is focusing
 in high tech medical companies like JRSE which have such an innovative
 technology approach in multiple industries and applications. IFG is very
 enthusiastic about providing such a financial commitment to JRSE to expand
 research and execute on business opportunities."
     Jacobson Resonance Enterprises (OTC-BB-JRSE) is a leader in the field of
 bio-electromagnetic resonance technology with multiple applications in the
 field of healthcare, agriculture, food and beverage, construction and the
 environment.
     Institutional Finance Group, Inc. and IFG Private Equity LLC are Atlanta-
 based institutional investment and funding companies.
     This press release contains forward-looking statements within the meaning
 of the Private Securities Litigation Reform Act of 1995. The matters covered
 by such forward-looking statements are subject to known and unknown risks,
 uncertainties and other factors which may cause actual results, performance or
 achievements of the Company to differ materially from those contemplated or
 implied by such forward-looking statements. For further information, contact
 Frank Chaviano at (561) 752-4141.
 
 

SOURCE Jacobson Resonance Enterprises, Inc.
    BOYNTON BEACH, Fla., and ATLANTA, April 11 /PRNewswire/ --
 Jacobson Resonance Enterprises, Inc. (OTC Bulletin Board:   JRSE) announced
 today the execution of a letter of intent subject to a more definitive
 agreement of an irrevocable three (3) year funding commitment with
 Institutional Finance Group, and IFG Private Equity LLC for ten million
 dollars ($10,000,000).
     While all the details have not been made public and are subject to final
 approval and due diligence by both Companies the irrevocable three-year
 commitment from IFG calls for providing JRSE with a maximum equity available
 line of ten million dollars ($10,000,000) based on ninety-five percent (95%)
 of the market price per share of JRSE stock averaged over the next twenty (20)
 days of trading of each pricing period. JRSE has the right and control to set
 up a floor price for the stock if and when it wishes to utilize said equity
 line during the three (3) year irrevocable commitment.
     IFG has already commenced its due diligence process which is expected to
 be concluded within the next few weeks and final approval and definitive
 lending agreement to be executed is anticipated within the next thirty (30)
 days.
     Dan Hollis, Chief Operating Officer of IFG said, "Our company is focusing
 in high tech medical companies like JRSE which have such an innovative
 technology approach in multiple industries and applications. IFG is very
 enthusiastic about providing such a financial commitment to JRSE to expand
 research and execute on business opportunities."
     Jacobson Resonance Enterprises (OTC-BB-JRSE) is a leader in the field of
 bio-electromagnetic resonance technology with multiple applications in the
 field of healthcare, agriculture, food and beverage, construction and the
 environment.
     Institutional Finance Group, Inc. and IFG Private Equity LLC are Atlanta-
 based institutional investment and funding companies.
     This press release contains forward-looking statements within the meaning
 of the Private Securities Litigation Reform Act of 1995. The matters covered
 by such forward-looking statements are subject to known and unknown risks,
 uncertainties and other factors which may cause actual results, performance or
 achievements of the Company to differ materially from those contemplated or
 implied by such forward-looking statements. For further information, contact
 Frank Chaviano at (561) 752-4141.
 
 SOURCE  Jacobson Resonance Enterprises, Inc.